Effects of Social Gaze Training on Brain and Behavior in Fragile X Syndrome

Sponsor
Stanford University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02616796
Collaborator
(none)
60
1
2
68
0.9

Study Details

Study Description

Brief Summary

The purpose of the study is to evaluate a 2-3 day treatment probe targeted to improving social gaze behavior in children with fragile X syndrome (FXS). The investigators will use the principles of Applied Behavior Analysis (ABA) to shape appropriate social skills. Importantly, the investigators propose to examine the effects of this treatment probe on brain and behavior.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Social gaze training
Phase 1/Phase 2

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Single (Care Provider)
Primary Purpose:
Treatment
Official Title:
Effects of Social Gaze Training on Brain and Behavior in Fragile X Syndrome
Study Start Date :
Apr 1, 2015
Anticipated Primary Completion Date :
Dec 1, 2020
Anticipated Study Completion Date :
Dec 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Social gaze training

Appropriate social gaze behavior will be reinforced using the principles of Applied Behavior Analysis.

Behavioral: Social gaze training
Appropriate social gaze behavior will be shaped using the principles of Applied Behavior Analysis.

No Intervention: No Training

Appropriate social gaze behavior will not be reinforced.

Outcome Measures

Primary Outcome Measures

  1. Percentage of social gaze aversion recorded during the social challenge [3 days]

  2. Heart rate recorded during the social challenge [3 days]

  3. Total t-score on the Social Responsiveness Scale (SRS) [4 weeks]

Secondary Outcome Measures

  1. Verbal responses and pauses in conversation observed during the social challenge [3 days]

  2. Fractional Amplitude of Low Frequency fluctuations (fALLF) measured in the insular cortex [3 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 18 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Boys diagnosed with fragile X syndrome

  2. Boys with intellectual disability who do not have FXS or other known genetic disorder associated with intellectual disability

  3. Age 8 to 18 years inclusive

  4. Ability to travel to Stanford

  5. Vineland Adaptive Behavior Scales standard score between 50 and 75 points

Exclusion Criteria:
  1. Sensory impairments, or any other serious medical or neurological condition that affects growth or development (e.g., seizure disorder, diabetes, congenital heart disease).

  2. Materials in body that would preclude an MRI scan (e.g., dental braces).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stanford University School of Medicine Stanford California United States 94305

Sponsors and Collaborators

  • Stanford University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Scott Hall, Associate Professor, Stanford University
ClinicalTrials.gov Identifier:
NCT02616796
Other Study ID Numbers:
  • 31648
First Posted:
Nov 30, 2015
Last Update Posted:
May 1, 2019
Last Verified:
Apr 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 1, 2019